The platform is crucial in epidemiology because it enables large-scale studies on health data without compromising patient privacy. This capability is especially valuable during public health emergencies, such as the COVID-19 pandemic, where rapid access to data can inform policy decisions and clinical guidelines. OpenSAFELY allows epidemiologists to conduct population-based studies that can lead to a better understanding of disease trends, risk factors, and the effectiveness of interventions.
